Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX1031 in non-constipating irritable bowel syndrome
NCT00813098Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Dec 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of telotristat ethyl in irritable bowel syndrome (IBS) (3 arms), sponsored by Lexicon Pharmaceuticals, Inc. Primary endpoint: Subjects Who Experienced Relief of IBS Pain and Discomfort at Week 4. Started Dec 2008; status: completed.
02
Drugs
telotristat ethyl
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00813098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813098.